Le Lézard
Classified in: Health
Subject: PER

Gravity Diagnostics Appoints Mary E. Talbott as Chief Legal Officer and Secretary


COVINGTON, Ky., Sept. 16, 2020 /PRNewswire/ -- Gravity Diagnostics, a CLIA laboratory licensed in all 50 states, has announced the hire of Mary E. Talbott as Chief Legal Officer and Secretary. 

Before joining Gravity Diagnostics, Mary spent more than 25 years in corporate and private practice. She most recently served as Senior Vice President, General Counsel and Corporate Secretary for Tennant Company in Minneapolis, MN. Before Tennant, Mary was Vice President, Assistant General Counsel and Assistant Corporate Secretary for General Cable Corporation.   

"I was attracted to Gravity Diagnostics based on their genuine commitment to pay it forward and make an impact in changing healthcare for the better," said Talbott. Gravity Diagnostic's dedication and success in meeting unprecedented demands, while maintaining integrity in its business dealings and relationships, is a rare combination, and I am very excited to join this team."

Mary earned her J.D. at Salmon P. Chase College of Law and her B.A. from Northern Kentucky University and began her career as a litigator practicing with Schletker, Hornbeck & Moore, and Greenebaum, Doll & McDonald PLLC. Her professional background includes various leadership and board advisory roles with Macy's, Scripps Networks Interactive Inc., The E. W. Scripps Company, and Cincinnati Bell. 

"Mary is joining our team at a critical time for us to scale our operations and maintain the highest level of compliance, a core value of Gravity Diagnostics, said Tony Remington, Chief Executive Officer, Gravity Diagnostics. "Her expertise and experience at large, public organizations are invaluable for planning for the future of Gravity Diagnostics."  

Gravity Diagnostics announces Mary's appointing after the most recent announcement of leadership hire Eric Spencer, Controller and Sales and Laboratory leadership team members announced earlier this year. Gravity has added over 150 employees to their workforce this year across departments including, but not limited to, data entry, laboratory, technology, sales, and customer support.

About Gravity Diagnostics
Gravity Diagnostics is a full-service, state-of-the-art CLIA laboratory licensed in all 50 states providing innovative laboratory testing including Infectious Diseases, Toxicology, and Pharmacogenomics. We advocate for physicians, patients, and our communities, supporting them with unsurpassed integrity, regulatory compliance, and clinical expertise. Our pledge to deliver the highest professional operating standards in the laboratory service industry, coupled with ongoing research and support, exemplifies our commitment to being provider engaged, patient-focused, and make the communities we serve a healthier place to live. Learn more about the work we are doing at gravitydiagnostics.com/media

Media Contact: [email protected] 

SOURCE Gravity Diagnostics


These press releases may also interest you

at 14:45
With safe seated mammography trending in the U.S., the Samuel U. Rodgers Health Center (Sam Rodgers) reports its use of the Danish made VELA Mammography Chair has provided significant physical benefits for patients, health benefits for mammographers,...

at 14:35
MD Logic Health® is excited to announce a groundbreaking partnership with renowned Nutritional Therapy Practitioner, Liz Wolfe, to launch an innovative new supplement, Daily Aminos+. This collaboration combines MD Logic Health®'s expertise in...

at 14:34
Last week, the Internal Revenue Service (IRS) issued a groundbreaking announcement on the tax treatment of work-life referral services provided to employees under an employer's work-life referral program. This development marks a significant...

at 14:30
Summer Health, a digital health company offering 24/7 pediatric support to parents, announced $11.65M in Series A Funding, co-led by new investor 7wire Ventures and returning investor Lux Capital. Returning investors Sequoia Capital, Metrodora...

at 13:56
Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17) and adult patientsGastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a rare cancer that...

at 13:40
Jesse Patterson has always been more of a self-treatment type of guy when it comes to dealing with his health. So, when the normally active 73-year-old New Holland resident started getting short of breath and felt his lungs burning when he walked any...



News published on and distributed by: